Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.52 is 653% above its 4-year average of -0.09, near the high end of its 4-year range (-1.70–1.20).
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-07-03): 0.37.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:08:46.530Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.52
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
-0.56
EARNINGS PER SHARE (EPS) AVG 5Y
-0.09
EARNINGS PER SHARE (EPS) AVG 10Y
0.23
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+193.41%
CURRENT VS 5Y AVG
+653.19%
CURRENT VS 10Y AVG
+122.22%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Varex Imaging Corporation
Market Cap
$778.01M
Earnings Per Share (EPS)
0.52
TTM Avg
N/A
3Y Avg
-0.56
5Y Avg
-0.09
Market Cap
$777.34M
Earnings Per Share (EPS)
-0.15
TTM Avg
-0.39
3Y Avg
-0.55
5Y Avg
-0.57
Market Cap
$776.24M
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.20
3Y Avg
-0.27
5Y Avg
-0.29
Market Cap
$785.03M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.05
3Y Avg
-1.18
5Y Avg
-0.72
Market Cap
$789.34M
Earnings Per Share (EPS)
-0.20
TTM Avg
0.10
3Y Avg
-0.30
5Y Avg
-1.16
Market Cap
$765.30M
Earnings Per Share (EPS)
-0.75
TTM Avg
-1.06
3Y Avg
-1.25
5Y Avg
-1.46
Market Cap
$761.37M
Earnings Per Share (EPS)
0.84
TTM Avg
0.43
3Y Avg
-11.54
5Y Avg
-7.53
Market Cap
$753.02M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.23
3Y Avg
-1.23
5Y Avg
-1.23
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Varex Imaging Corporation (VREX) | $778.01M | 0.52 | N/A | -0.56 | -0.09 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -0.15 | -0.39 | -0.55 | -0.57 |
| Geron Corporation (GERN)vs › | $776.24M | -0.10 | -0.20 | -0.27 | -0.29 |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | -1.68 | 0.05 | -1.18 | -0.72 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | -0.20 | 0.10 | -0.30 | -1.16 |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | -0.75 | -1.06 | -1.25 | -1.46 |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 0.84 | 0.43 | -11.54 | -7.53 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | N/A | -1.23 | -1.23 | -1.23 |
| InMode Ltd. (INMD)vs › | $804.16M | 1.23 | 1.87 | 2.02 | 1.86 |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | -1.18 | -1.05 | -1.11 | -0.92 |
Trailing EPS (TTM)
$0.52
Forward EPS (Est.)
$1.07
P/E Ratio
35.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-10-03 | -1.70 |
| 2024-09-27 | -1.17 |
| 2023-09-29 | 1.20 |
| 2022-09-30 | 0.76 |
| 2021-10-01 | 0.44 |
| 2020-10-02 | -1.49 |
| 2019-09-30 | 0.41 |
| 2018-09-30 | 0.73 |
| 2017-09-30 | 1.37 |
| 2016-09-30 | 1.79 |
| 2015-09-30 | 2.09 |
| 2014-09-30 | 2.88 |
| 2013-09-30 | 2.87 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T21:08:46.530Z. Historical observations retain their original dates. Historical series through 2024-11-19.
